24Jul 2017

COMPARATIVE QUALITY EVALUATION OF DIFFERENT OLMESARTAN MEDOXOMIL GENERIC TABLETS MARKETED IN BANGLADESH.

  • Faculty of Medicine, Department of Pharmacy, University of Asia Pacific, 74/A Green Road, Dhaka-1215, Bangladesh.
Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

The objective of the present study was to evaluate and compare between nine different brands of Olmesartan medoxomil 40mg which are commercially available in Bangladeshi market. We chose nine popular brands, coded them from O1 to O9 and purchased them from local private pharmacies .The physicochemical equivalence of nine brands were determined through the evaluation of both official and non-official standards according to the USP pharmacopoeia including uniformity of weight, thickness, diameter, friability, hardness, disintegration, dissolution rate and drug content. All the tested brands conformed to the official tests for weight variation, friability, disintegration and dissolution tests. The friability test was within the specified limit (except for Brand O2). All formulations disintegrated within 15-30min. The percentage content of active ingredient of almost all brands of Olmesartan medoxomil tablets showed values within the monograph specifications (95-105%). The dissolution profiles showed inter and intra brand variability but all samples attained 75% dissolution within 45mins and complied with USP monograph. The nine brands evaluated in this study could be considered biopharmaceutically and chemically equivalent and it had been determined calculating difference factor and similarity factors. Moreover, the result of all these parameters of different brands were in the pharmacopoeia limits. So it could be concluded that marketed pharmaceutical tablets of Olmesartan medoxomil of these brands are safe, effective and efficacious as well as satisfy quality control limits of pharmacopoeia.. Therefore, patients can safely shift from one brand to another.

  1. Shyamala, B., Narmada, G.Y. (2002): Rapid dissolving tablets: A novel dosage form. The Ind. Pharmacist, 13(8): 09-12.
  2. Sreenivas, S.A., Dandagi, P.M., Gadad, A.P., Godbloe, A.M., Hiremath, S.P. (2005): Mastiholimath VS. Orodispersible tablets: New-fangled drug delivery systems ? A review. J. Pharm. Educ. Res., 39(4): 177-181.
  3. Seager, H. (1998): Drug-delivery products and Zydis Fast-dissolving dosage form. J. Pharm. Pharmacol., 50: 375-382.
  4. Bradoo, R., Shahani, S., Deewan, B., Sudarshan, S. (2001): Fast dissolving drug delivery system. J. Med. Assoc. Ind., 4 (10): 27-31.
  5. Valleri, ,? Mura,? P.,? Maestrelli,? F.,? Cirri,? M.,? Ballerini,? R. (2004): Development? and? evaluation? of? glyburide? fast dissolving??? tablets??? using??? solid??? dispersion technique.? Drug Dev. Ind. Pharm., 30(5): 525-34.
  6. Gilbert, S.B., Neil, R.A. (2011): Tablets. In Lachman L, Lieberman HA, kanig JL, The theory and practice of industrial pharmacy 3rd edition. Editors: U.S.A, Lea & Febigerverghese publishing House, pp 293-340.
  7. Rasenack, N., M?ller, B.W. (2002): Crystal habit and tableting behavior. International J. of Pharm., 244(1-2):45-57.
  8. Hansen, T., Holm, P., Schultz, K. (2004): Process characteristics and compaction of spray- dried emulsions containing a drug dissolved in lipid. International Journal of Pharmacy, 287(1-2):55-66.
  9. Bozic, D.Z., Dreu, R., Vrecer, F. (2008): Influence of dry granulation on compactibility and capping tendency of macrolide antibiotic formulation. International Journal of Pharmacy,
357: 44-54.
  1. Alderborn, G., Nystr?m, C. (1996): Pharmaceutical powder compaction technology. New York: Marcel Dekker, 610.
  2. Koly, K.N., Biswas, T., Islam, A. (2010): Increasing Prevalence of Hypertension in Bangladesh: A review.
  3. Giles, T.D., Oparil, S., Silfani, T.N., Wang, A., Walker, J.F. (2007): Comparison of increasing doses of olmesartan medoxomil, losartan potassium, and valsartan in patients with essential hypertension. J. Clin Hypertens (Greenwich), 9:187-195.
  4. Scott, L.J., McCormack, P.L. (2008): Olmesartan Medoxomil. Drugs, 68(9):1239-72.
  5. British Pharmacopeia (BP), Her Majesty?s Stationary Office, London, 2013.
  6. Du, J., Hoag, S.W. (2003): Characterization of excipient and tableting factors that influence folic acid dissolution, friability, and breaking strength of oil- and water soluble multivitamin with mineral tablets. Drug Development and Industrial Pharmacy, 29:1134-1147.
  7. Pisek, R., Korselj, V., Vrecer, F. (2011): Comparison of direct rotor pelletization (fluid bed) and hign shear pelletization method for pellet production. Pharm and Biopharm, 53:327-333.
  8. US Pharmacopeia National Formulary USP 23/NF 18. United States Pharmacopeial Convention. Inc., Rockville, MD, 1995.
  9. Du, J., Hoag, S.W. (2003): Characterization of excipient and tableting factors that influence folic acid dissolution, friability, and breaking strength of oil- and water soluble multivitamin with mineral tablets. Drug Dev. and Indus. Pharm., 29:1134- 1147.
  10. Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system; guidance for industry; U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), U.S. Government Printing Office: Washington, DC, 2000.

[Tasnova Tasnim and Monirul Hasan. (2017); COMPARATIVE QUALITY EVALUATION OF DIFFERENT OLMESARTAN MEDOXOMIL GENERIC TABLETS MARKETED IN BANGLADESH. Int. J. of Adv. Res. 5 (Jul). 1403-1410] (ISSN 2320-5407). www.journalijar.com

TASNOVA TASNIM
In writing the manuscript

DOI:

Article DOI: 10.21474/IJAR01/4852      
DOI URL: https://dx.doi.org/10.21474/IJAR01/4852

Download Full Paper

Download PDF No. of Downloads: 37 | No. of Views: 182